NCT06124196View on ClinicalTrials.gov

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

February 28, 2030

Study Completion Date

February 28, 2031

Conditions
Duchenne Muscular Dystrophy
Interventions
DEVICE

wearable technology

Three wearable devices

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER